Daventry Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-70,010
Closed -$10.7M 9
2024
Q1
$10.7M Buy
70,010
+9,673
+16% +$1.61M 4.27% 9
2023
Q4
$18.9M Buy
+60,337
New +$21.8M 8.13% 7

Other funds holding AGL

Daventry Group's AGL Position: Q2 2024 in Review

Daventry Group sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 70,010 shares — an estimated $10.7M sold.

Daventry Group first reported a position in AGL in Q4 2023 and held it in 2 quarters. The position peaked at $18.9M in Q4 2023. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

  • Daventry Group reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
  • Daventry Group sold 70,010 Agilon Health shares in Q2 2024, an estimated $10.7M.
  • Daventry Group first reported a position in Agilon Health in Q4 2023 and held it in 2 quarters.
  • Daventry Group's Agilon Health position peaked at $18.9M in Q4 2023.
  • 201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on Daventry Group's 13F filing for Q2 2024, filed 14 Aug 2024.